Absorption |
Blood-Brain Barrier | BBB+ | 0.9642 |
Human Intestinal Absorption | HIA+ | 0.9680 |
Caco-2 Permeability | Caco2+ | 0.7337 |
P-glycoprotein Substrate | Substrate | 0.8532 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8781 |
Non-inhibitor | 0.8923 |
Renal Organic Cation Transporter | Inhibitor | 0.5431 |
Distribution |
Subcellular localization | Mitochondria | 0.4758 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8645 |
CYP450 2D6 Substrate | Substrate | 0.5896 |
CYP450 3A4 Substrate | Substrate | 0.5919 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9421 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9029 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9300 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9562 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7470 |
Non-inhibitor | 0.8054 |
AMES Toxicity | Non AMES toxic | 0.6897 |
Carcinogens | Non-carcinogens | 0.9598 |
Fish Toxicity | High FHMT | 0.5436 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8758 |
Honey Bee Toxicity | Low HBT | 0.6156 |
Biodegradation | Not ready biodegradable | 0.9796 |
Acute Oral Toxicity | III | 0.5841 |
Carcinogenicity (Three-class) | Non-required | 0.5375 |